InvestorsHub Logo
Followers 14
Posts 289
Boards Moderated 0
Alias Born 04/19/2013

Re: ClosetInvestor post# 18092

Tuesday, 09/15/2015 4:31:08 AM

Tuesday, September 15, 2015 4:31:08 AM

Post# of 462733
Epilepsy drug is in pre-clenical stage, hasn't even applied for phase 1, here's the link from there own website with pipeline and stages.

http://www.anavex.com/pipeline/


Anavex Plus is for Alzheimer's, Anavex 2-73 was submitted under the treatment of Alzheimer's. From what I understand, in testing even if a candidate has shown progress towards anything other then what it was submitted for, it cant be approved for that. But once approved, Anavex 2-73 can be prescribed by a Dr. for reasons it wasn't made for. Which happens to a ton of medication. Preclinical is close to a 7-10 year time frame of approval. Also as hard as it is to discover anykind of new medication, preclinical I believe is like a 1% chance of making it through. Those numbers are deceiving thou cause there's a ton of preclinical stuff that's nonsense bs.

Also the Epilepsy drug has been going since 2008. Started as A-73 ans A-144 combination i believe if i recall right. Have no idea what happened to A-144. So 7 years and still hasn't gotten that far. Only been tested on animals, not one human test go date that I can find of.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News